Latin America HPLC Market

Latin America HPLC Market Size (2024 to 2029)

The size of the High-Performance Liquid Chromatography Market in Latin America was around USD 197.69 Million in 2024. It is expected to grow at a CAGR of 4.8% to reach 249.92 million by 2029.

The HPLC technique is used for drug analysis, separation, and purification of liquids and environmental monitoring in the pharmaceutical & biopharmaceutical industries. Growing environmental pollution and the need to monitor ecological conditions have increased HPLC use in the environmental sector.

The growth of this market is mainly driven by the high sensitivity and precision of the HPLC technique; dominantly, the adoption is seen in food and pharmaceutical industries due to the growing importance of drug approvals, the analysis for food and drugs for nutritional components, for purification of monoclonal antibodies and the increase in proteomics and cellular studies. In addition, the growing emphasis on accurate diagnostics and the testing of the validity and specificity of drugs is expected to continue to drive the Latin America HPLC market in the future.

HPLC techniques have also entered forensic science, where they are used to identify the presence of illegal and therapeutic drugs in bodily fluids or tissue samples. Furthermore, increased research and development for drug analysis have increased the drug approval process, which has evolved the regional market for HPLC during the forecast period. In addition, the increasing use of packaged and processed foods has increased the use of HPLC in the food industry, making the HPLC systems more reliable and famous during the past few years.

Other factors such as technical advancements leading to an increasing number of pharmaceuticals companies coupled with favorable funds for R&D for therapies, this increases the demand for purification and separation techniques such as HPLC, are estimated to drive the growth of the Latin America HPLC market.

However, certain factors such as the high cost of HPLC systems and lack of qualified professionals are expected to restrain the market's growth to some extent.

This research report on the Latin American HPLC market has been segmented and sub-segmented into the following categories.

Latin America HPLC Market Analysis By Product

• Instruments
• Consumables
• Accessories

By Instruments:

• Systems
• Detectors

Latin America HPLC Market Analysis By Consumables

• Columns
• Filters

Latin America HPLC Market Analysis By Application

• Clinical Research
• Diagnostics
• Forensics

Latin America HPLC Market Analysis By Country

• Brazil
• Argentina
• Chile
• Mexico
• Rest of Latin America

The Latin America high-performance liquid chromatography (HPLC) market is expected to develop significantly in the future owing to the ‘Free Trade Treaties (FTA)’ which has reduced the taxes and studies on HPLC in biosciences and pharmaceutical sectors during the forecast period, that is, say from 2024 to 2029.

The Brazilian HPLC market led the Latin America market in 2024, growing at a CAGR of 4.4% during the forecast period. The Brazilian HPLC market growth is primarily attributable to increasing R&D funds, the growing attraction of international pharmaceutical companies in the region, and the food and agriculture industry development. In addition, the increased prevalence of chronic disease and their early intervention has led to the growth of diagnostic studies for HPLC in the regional market. Furthermore, factors such as the strong sales of biosimilars and generics are also helping develop the pharmaceutical and biotechnology sectors in Brazil.

On the other hand, the Mexican HPLC market is expected to be growing at a promising CAGR during the forecast period. The region's high growth rate is due to the improved regulatory environment and high foreign investment made by the Mexican pharmaceutical market. The Mexican pharmaceutical sector was valued at $ 15.55 billion in 2013. Mexico is the twelfth largest pharmaceutical market in the world, the second in Latin America after Brazil. Annual drug/pharmaceutical sales of 3,500 million units are reported in Mexico. Between 1999 and 2006, the industry grew by over 20% and 16% more between 2008 and 2010. This steady growth will benefit pharmaceutical sales in Latin American countries in the future. In addition, government initiatives are aimed at developing small-scale industries, which will create growth opportunities as well as the entry of existing newer kits in Mexico, this is expected to influence the growth of the market.

KEY MARKET PLAYERS

A few prominent companies in the Latin America HPLC market profiled in this report are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific Inc., GE Healthcare, PerkinElmer Inc. Bio-Rad Laboratories Inc., Gilson Inc., Phenomenex Inc., and JASCO Inc.